Ortin GlobalBOM:539287 -0.17%43 Operating Margin % is -22.38% as of Mar. 2026. GuruFocus rates BOM:539287 with a GF Score™ of 43/100 and a GF Value™ of ₹2.56 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 952 Drug Manufacturers companies, Ortin Global ranks worse than 95.9% on this metric.
Operating Margin % is calculated as Operating Income divided by its Revenue. Ortin Global's Operating Income for the
three
months ended in Mar. 2026 was ₹-0.08 Mil. Ortin Global's Revenue for the
three
months ended in Mar. 2026 was ₹0.34 Mil. Therefore, Ortin Global's Operating Margin % for the quarter that ended in Mar. 2026 was -22.38%.
The historical rank and industry rank for Ortin Global's Operating Margin % or its related term are showing as below:
BOM:539287'
s Operating Margin % Range Over the Past 10 Years
Min: -717.61 Med: 3 Max: 11.75
Current: -717.61
BOM:539287's Operating Margin % is ranked worse than 95.9% of 952
companies
in the Drug Manufacturers industry
Industry Median: 7.58
vs BOM:539287: -717.61
Ortin Global's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.
Ortin Global's Operating Income for the
three
months ended in Mar. 2026 was ₹-0.08 Mil.
Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-7.21 Mil.
Ortin Global (BOM:539287) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Ortin Global Operating Margin % Related Terms
Ortin Global Operating Margin % Historical Data
* Premium members only.
The historical data trend for Ortin Global's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:539287 vs ZTS, UTHR: Operating Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Ortin Global's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ortin Global Operating Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ortin Global's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Ortin Global's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Ortin Global's Operating Margin % for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ortin Global (BOM:539287) has a Operating Margin % of -22.38% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Ortin Global and its competitors. According to the industry distribution chart, Ortin Global ranks #913 out of 952 companies in the Drug Manufacturers industry, placing it in the top 95.9%.
Is Ortin Global's Operating Margin % too high?
Ortin Global's current Operating Margin % is -22.38%. Based on the distribution chart, Ortin Global ranks #913 out of 952 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Ortin Global has a GF Score™ of 43/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ortin Global's Operating Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Ortin Global ranks #913 out of 952 companies for Operating Margin %. This places Ortin Global in the lower half of its industry. The industry median Operating Margin % is 7.58. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Drug Manufacturers company?
The median Operating Margin % among Drug Manufacturers companies is 7.58, based on 952 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Ortin Global and its competitors. For the Drug Manufacturers industry, the median Operating Margin % is 7.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ortin Global's current Operating Margin % is -22.38%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ortin Global stock overvalued right now?
Based on GuruFocus' analysis, Ortin Global (BOM:539287) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹2.56, compared to a current price of ₹17.25 — trading 573.8% above its estimated fair value. The current Operating Margin % is -22.38%. Ortin Global's overall GF Score™ is 43/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Ortin Global (BOM:539287), the current Operating Margin % is -22.38% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ortin Global (BOM:539287) Overvalued in 2026?
Based on GuruFocus' analysis, Ortin Global stock appears to be overvalued.
The current stock price of ₹17.25 is trading 573.8% above its estimated GF Value™ of ₹2.56.
GuruFocus considers Ortin Global to be Significantly Overvalued.
Key valuation signals for BOM:539287:
Operating Margin %: -22.38%
GF Value™: ₹2.56 vs. price of ₹17.25 (573.8% above fair value)
No single metric tells the full story. See the BOM:539287 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ortin Global Ltd is an Indian company engaged in the manufacturing and trading of Pharmaceuticals, Drugs, and Intermediates. Its formulations include anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helminthics, analgesics and antipyretics, antibiotics, antifungal, cephalosporins, and others. Some of its API intermediates include Ciprofloxacin, Tramadol, Efavarenz, Lamivudine, Zidovudine, Nevirapine, Lopinavir, Fluconazole, Triclabendazole, Omeprazole, and others. Additionally, the company is also involved in the real estate business.
43GF Score
Get the complete analysis for BOM:539287
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:539287 has been successfully added to your 
